US Stock MarketDetailed Quotes

ABVC ABVC BioPharma

Watchlist

1.4000
-0.0200-1.41%

Close Apr 29 16:00 ET

1.4197
+0.0197+1.41%

Post 19:57 ET

14.78MMarket Cap-576P/E (TTM)

ABVC BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

42.75%-4.24M

-3.99%-479.46K

-164.53%-1.36M

73.76%-899.83K

49.98%-1.5M

2.62%-7.4M

81.74%-461.07K

76.82%-513.7K

-137.49%-3.43M

-111.90%-2.99M

Net income from continuing operations

33.12%-10.91M

26.02%-3.33M

10.82%-3.37M

-18.89%-2.32M

68.83%-1.9M

-35.53%-16.31M

34.78%-4.5M

-100.21%-3.78M

5.14%-1.95M

-409.29%-6.09M

Operating gains losses

--221.89K

----

Depreciation and amortization

19.88%28.53K

17.82%7.58K

15.43%7.46K

27.43%7K

20.00%6.49K

98.44%23.8K

96.91%6.44K

126.26%6.46K

86.71%5.49K

84.80%5.41K

Deferred tax

-86.62%115.67K

-83.11%151.39K

-184.55%-117.41K

198.13%81.7K

--0

4.93%864.8K

-11.39%896.05K

283.53%138.87K

-37.91%-83.25K

-70.25%-86.87K

Other non cash items

7,361.35%2.41M

55,408.62%991.38K

10,976.26%1.3M

1,232.60%124.31K

-116.01%-1.52K

108.96%32.35K

101.71%1.79K

108.87%11.73K

--9.33K

107.64%9.5K

Change In working capital

26.47%803.8K

-111.38%-164.29K

-99.92%1.79K

157.23%938.16K

101.84%28.14K

139.38%635.57K

245.83%1.44M

633.32%2.36M

-1,296.21%-1.64M

-378.91%-1.53M

-Change in receivables

93.58%-93.22K

-8.88%-474.24K

-75.07%356.28K

102.19%22.12K

100.18%2.62K

-102.67%-1.45M

54.96%-435.56K

256.69%1.43M

-1,043.31%-1.01M

-458.93%-1.43M

-Change in inventory

----

--0

----

105.05%3.01K

---64

--2.54K

-Change in prepaid assets

-57.19%101.93K

1,588.08%74K

-97.35%27.2K

130.43%204.34K

-79.73%-203.62K

166.64%238.09K

-101.72%-4.97K

340.02%1.03M

-2,045.32%-671.42K

39.65%-113.29K

-Change in payables and accrued expense

-61.49%712.88K

-88.38%219.95K

-274.82%-381.69K

1,436.53%645.48K

1,111.02%229.14K

460.48%1.85M

645.84%1.89M

71.31%-101.83K

-32.65%42.01K

-84.94%18.92K

-Change in other current liabilities

626.92%13.7K

715.38%16K

--0

----

---2.6K

--0

----

-Change in other working capital

--68.52K

---1

--0

----

Cash from discontinued investing activities

Operating cash flow

42.75%-4.24M

-3.99%-479.46K

-164.53%-1.36M

73.76%-899.83K

49.98%-1.5M

2.62%-7.4M

81.74%-461.07K

76.82%-513.7K

-137.49%-3.43M

-111.90%-2.99M

Investing cash flow

Cash flow from continuing investing activities

79.08%-360.19K

285.11%154.17K

95.16%-73.78K

-1,900.25%-440.58K

-113.62%-1.72M

-119.51%-83.29K

-87.85%-1.52M

84.27%-22.03K

66.94%-93.22K

Net PPE purchase and sale

82.29%-21.2K

--0

-386.60%-21.2K

--0

-583.84%-119.69K

---89

75.11%-4.36K

---22.03K

---93.22K

Net business purchase and sale

78.84%-338.99K

----

-135.27%-1.6M

----

Net investment purchase and sale

----

96.54%-52.58K

----

---1.52M

----

Cash from discontinued investing activities

Investing cash flow

79.08%-360.19K

285.11%154.17K

95.16%-73.78K

-1,900.25%-440.58K

--0

-113.62%-1.72M

-119.51%-83.29K

-87.85%-1.52M

84.27%-22.03K

66.94%-93.22K

Financing cash flow

Cash flow from continuing financing activities

-2.37%3.92M

134.49%87.42K

174.49%1.66M

-100.86%-31.59K

2.21M

-59.84%4.01M

-105.96%-253.5K

-89.63%603.5K

3,232.63%3.66M

Net issuance payments of debt

32.18%462.62K

--110.11K

-620.71%-1.82M

---31.59K

--2.21M

227.98%350K

--0

269.00%350K

--0

Net common stock issuance

-71.34%1.05M

--0

314.20%1.05M

----

-67.05%3.66M

-105.97%-253.5K

-96.31%253.5K

----

Proceeds from stock option exercised by employees

--2.41M

---22.69K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

-2.37%3.92M

134.49%87.42K

174.49%1.66M

-100.86%-31.59K

--2.21M

-59.84%4.01M

-105.96%-253.5K

-89.63%603.5K

3,232.63%3.66M

--0

Net cash flow

Beginning cash position

-78.80%1.39M

-43.10%1.12M

-79.38%742.19K

-47.80%1.79M

-78.80%1.39M

31.27%6.57M

-55.72%1.97M

117.21%3.6M

2.98%3.43M

31.27%6.57M

Current changes in cash

86.74%-677.07K

70.19%-237.87K

115.62%223.83K

-745.53%-1.37M

122.96%708.95K

-420.77%-5.11M

-137.02%-797.86K

-151.36%-1.43M

112.49%212.54K

-86.80%-3.09M

Effect of exchange rate changes

103.15%2.12K

-175.78%-166.29K

179.14%154.92K

802.48%322.3K

-583.95%-308.8K

-140.31%-67.34K

654.14%219.44K

-9,162.27%-195.75K

-285.34%-45.88K

-194.42%-45.15K

End cash Position

-48.50%716.78K

-43.10%1.12M

-79.38%742.19K

-47.80%1.79M

-78.80%1.39M

-55.72%1.97M

117.21%3.6M

2.98%3.43M

Free cash flow

43.38%-4.26M

-3.97%-479.46K

-166.40%-1.38M

73.93%-899.83K

51.49%-1.5M

1.28%-7.52M

81.73%-461.16K

76.81%-518.06K

-139.02%-3.45M

-118.49%-3.09M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	42.75%-4.24M	-3.99%-479.46K	-164.53%-1.36M	73.76%-899.83K	49.98%-1.5M	2.62%-7.4M	81.74%-461.07K	76.82%-513.7K	-137.49%-3.43M	-111.90%-2.99M
Net income from continuing operations	33.12%-10.91M	26.02%-3.33M	10.82%-3.37M	-18.89%-2.32M	68.83%-1.9M	-35.53%-16.31M	34.78%-4.5M	-100.21%-3.78M	5.14%-1.95M	-409.29%-6.09M
Operating gains losses	--221.89K	----	----	----	----	----	----	----	----	----
Depreciation and amortization	19.88%28.53K	17.82%7.58K	15.43%7.46K	27.43%7K	20.00%6.49K	98.44%23.8K	96.91%6.44K	126.26%6.46K	86.71%5.49K	84.80%5.41K
Deferred tax	-86.62%115.67K	-83.11%151.39K	-184.55%-117.41K	198.13%81.7K	--0	4.93%864.8K	-11.39%896.05K	283.53%138.87K	-37.91%-83.25K	-70.25%-86.87K
Other non cash items	7,361.35%2.41M	55,408.62%991.38K	10,976.26%1.3M	1,232.60%124.31K	-116.01%-1.52K	108.96%32.35K	101.71%1.79K	108.87%11.73K	--9.33K	107.64%9.5K
Change In working capital	26.47%803.8K	-111.38%-164.29K	-99.92%1.79K	157.23%938.16K	101.84%28.14K	139.38%635.57K	245.83%1.44M	633.32%2.36M	-1,296.21%-1.64M	-378.91%-1.53M
-Change in receivables	93.58%-93.22K	-8.88%-474.24K	-75.07%356.28K	102.19%22.12K	100.18%2.62K	-102.67%-1.45M	54.96%-435.56K	256.69%1.43M	-1,043.31%-1.01M	-458.93%-1.43M
-Change in inventory	----	----	--0	--0	--0	----	----	105.05%3.01K	---64	--2.54K
-Change in prepaid assets	-57.19%101.93K	1,588.08%74K	-97.35%27.2K	130.43%204.34K	-79.73%-203.62K	166.64%238.09K	-101.72%-4.97K	340.02%1.03M	-2,045.32%-671.42K	39.65%-113.29K
-Change in payables and accrued expense	-61.49%712.88K	-88.38%219.95K	-274.82%-381.69K	1,436.53%645.48K	1,111.02%229.14K	460.48%1.85M	645.84%1.89M	71.31%-101.83K	-32.65%42.01K	-84.94%18.92K
-Change in other current liabilities	626.92%13.7K	715.38%16K	--0	----	----	---2.6K	---2.6K	--0	----	----
-Change in other working capital	--68.52K	---1	--0	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	42.75%-4.24M	-3.99%-479.46K	-164.53%-1.36M	73.76%-899.83K	49.98%-1.5M	2.62%-7.4M	81.74%-461.07K	76.82%-513.7K	-137.49%-3.43M	-111.90%-2.99M
Investing cash flow
Cash flow from continuing investing activities	79.08%-360.19K	285.11%154.17K	95.16%-73.78K	-1,900.25%-440.58K	0	-113.62%-1.72M	-119.51%-83.29K	-87.85%-1.52M	84.27%-22.03K	66.94%-93.22K
Net PPE purchase and sale	82.29%-21.2K	--0	-386.60%-21.2K	--0	--0	-583.84%-119.69K	---89	75.11%-4.36K	---22.03K	---93.22K
Net business purchase and sale	78.84%-338.99K	----	----	----	----	-135.27%-1.6M	----	----	----	----
Net investment purchase and sale	----	----	96.54%-52.58K	----	----	----	----	---1.52M	----	----
Cash from discontinued investing activities
Investing cash flow	79.08%-360.19K	285.11%154.17K	95.16%-73.78K	-1,900.25%-440.58K	--0	-113.62%-1.72M	-119.51%-83.29K	-87.85%-1.52M	84.27%-22.03K	66.94%-93.22K
Financing cash flow
Cash flow from continuing financing activities	-2.37%3.92M	134.49%87.42K	174.49%1.66M	-100.86%-31.59K	2.21M	-59.84%4.01M	-105.96%-253.5K	-89.63%603.5K	3,232.63%3.66M	0
Net issuance payments of debt	32.18%462.62K	--110.11K	-620.71%-1.82M	---31.59K	--2.21M	227.98%350K	--0	269.00%350K	--0	--0
Net common stock issuance	-71.34%1.05M	--0	314.20%1.05M	----	----	-67.05%3.66M	-105.97%-253.5K	-96.31%253.5K	----	----
Proceeds from stock option exercised by employees	--2.41M	---22.69K	----	----	----	--0	--0	----	----	----
Cash from discontinued financing activities
Financing cash flow	-2.37%3.92M	134.49%87.42K	174.49%1.66M	-100.86%-31.59K	--2.21M	-59.84%4.01M	-105.96%-253.5K	-89.63%603.5K	3,232.63%3.66M	--0
Net cash flow
Beginning cash position	-78.80%1.39M	-43.10%1.12M	-79.38%742.19K	-47.80%1.79M	-78.80%1.39M	31.27%6.57M	-55.72%1.97M	117.21%3.6M	2.98%3.43M	31.27%6.57M
Current changes in cash	86.74%-677.07K	70.19%-237.87K	115.62%223.83K	-745.53%-1.37M	122.96%708.95K	-420.77%-5.11M	-137.02%-797.86K	-151.36%-1.43M	112.49%212.54K	-86.80%-3.09M
Effect of exchange rate changes	103.15%2.12K	-175.78%-166.29K	179.14%154.92K	802.48%322.3K	-583.95%-308.8K	-140.31%-67.34K	654.14%219.44K	-9,162.27%-195.75K	-285.34%-45.88K	-194.42%-45.15K
End cash Position	-48.50%716.78K	-48.50%716.78K	-43.10%1.12M	-79.38%742.19K	-47.80%1.79M	-78.80%1.39M	-78.80%1.39M	-55.72%1.97M	117.21%3.6M	2.98%3.43M
Free cash flow	43.38%-4.26M	-3.97%-479.46K	-166.40%-1.38M	73.93%-899.83K	51.49%-1.5M	1.28%-7.52M	81.73%-461.16K	76.81%-518.06K	-139.02%-3.45M	-118.49%-3.09M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall